Based on these studies, it seems that antitumor immunity increases in endometrioid carcinoma as the histologic grade increases, and immune cells with increased HIF-1α expression increase around the tumor, and it is expected that maintaining HIF-1α expression in peritumor cells will be very helpful for tumor treatment [48]. This evidence concerns the gene HIF1A and endometrioid adenocarcinoma.